Modification of the radiation response by the administration of exogenous genes

Seminars in Radiation Oncology

Volumn 6, Issue 4, 1996, Pages 321-328

  Hanna, N N ^a   Hallahan, D E ^a   Wayne, J D ^a   Weichselbaum, R R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; CYTOSINE DEAMINASE; FLUOROURACIL; GANCICLOVIR; PRODRUG; THYMIDINE KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER; CANCER RADIOTHERAPY; EXPRESSION VECTOR; GENE TARGETING; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; IONIZING RADIATION; NONHUMAN; PRIORITY JOURNAL; RADIATION RESPONSE;

EID: 0029909609     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-4296(96)80027-0     Document Type: Article

References (66)

1. Fujiwara T Grimm EA Mukhopadhyay T A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis Cancer Res 53 1993 4129 4133
2. Fujiwara T Grimm EA Mukhopadhyay T Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene Cancer Res 54 1994 2287 2291
3. Chen YM Chen PL Arnaiz N Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate Oncogene 6 1991 1799 1805
4. Cai DW Mukhopadhyay T Liu Y Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer Hum Gene Ther 4 1993 617 624
5. Mickisch GH Licht T Merlino GT Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: Efficacy potency, and toxicity Cancer Res 51 1991 5417 5424
6. Mickisch GH Merlino GT Galski H Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance Proc Natl Acad Sci USA 88 1991 547 551
7. Huber BE Austin EA Richards CA Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase Proc Natl Acad Sci USA 91 1994 8302 8306
8. Hallahan DE Mauceri HJ Seung LP Spatial and temporal control of gene therapy by ionizing radiation Nature Med 786-791 1995
9. Crystal R The gene as the drug Nature Med 1 1995 15 17
10. Crystal R Transfer of genes to humans: Early lessons and obstacles to success Science 270 1995 404 409
11. Kozarsky KF Wilson JM Gene therapy: Adenovirus vectors Curr Opin Genet Devel 3 1993 499 503
12. Jones N Shenk T Isolation of Ad5 mutants defective for transformation Cell 17 1979 683 689
13. [Review] Berkner KL Development of adenovirus vectors for the expression of heterologous genes Biotechniques 6 1988 616 629
14. Martuza RL Malick A Markert JM Experimental therapy of human glioma by means of a genetically engineered virus mutant Science 252 1991 854 856
15. Mineta T Rabkin SD Martuza RL Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant Cancer Res 54 1994 3963 3966
16. Yazaki T Manz HJ Rabkin SD Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1 Cancer Res 55 1995 4752 4756
17. Casto BC Armstrong JA Atchison RW Studies on the relationship between adeno-associated virus type 1 (AAV-1) Virology 33 1967 452 458
18. Berns KI A.C Ostrove J Adeno-associated virus latent infection Mahy BWJ Minson AC Darby GK Virus Persistance 1982 Cambridge University Press Cambridge 249
19. Singhal A Huang L Gene transfer in mammalian cells using liposomes as carriers N Y Acad Sci 716 1994 118 142
20. Yang NS DeLuna C Cheng L Gene transfer via particle bombardment: Applications of the accell gene gun Wolff JA Gene Therapeutics: Methods and application of direct gene transfer 1994 BirkHauser Boston
21. Nishi T Yoshizato K Ysamashiro S High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation Cancer Res 56 1996 1050 1055
22. McCabe D Swain W Martinell B Stable transformation of soybean (glycine max) by particle acceleration Bio/Technology 6 1988 923 926
23. Klein T Wolf E Wu R High-velocity kicroprojectiles for delivering nucleic acids into living cells Nature 327 1987 70 73
24. Mir LM Orlowski S Belehradek JJ Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses Eur J Cancer 27 1991 68 72
25. Dev SB Hofmann GA Clinical applications of electroporation Lynch PT Davey MR The Electrical Manipulation of Cells 1995 Chapman and Hall New York 185 199
26. Belehradek M Domenge C Luboinski B Electrochemotherapy, a new antitumor treatment. First clinical phase I–II trial Cancer 72 1993 3694 3700
27. [Review] Weichselbaum RR Hallahan D Fuks Z Radiation induction of immediate early genes: Effectors of the radiation-stress response Int J Rad Oncol Biol Phys 30 1994 229 234
28. Weichselbaum R Fuks Z Radiation-induced cytokines and growth factors: Cellular and molecular basis of the modification of radiation damage Yarnold J Stratton M McMillan T Radiation-induced cytokines and growth factors: Cellular and molecular basis of the modification of radiation damage 1993 Elsevier Science London
29. Suresh A Tung F Moreb J Role of manganese superoxide dismutase in radioprotection using gene transfer studies Cancer Gene Therapy 1 1994 85 90
30. Chen M Quintans J Fuks Z Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide Cancer Res 55 1994 991 994
31. Fuks Z Persaud RS Alfieri A Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo Cancer Res 54 1994 2582 2590
32. [Review] Wong GH Protective roles of cytokines against radiation: Induction of mitochondrial MnSOD Biochim Biophys Acta 1271 1995 205 209
33. Neta R Douches S Oppenheim JJ Interleukin 1 is a radioprotector J Immunol 136 1986 2483 2485
34. Neta R Stiefel SM Finkelman F IL-12 protects bone marrow from and sensitizes intestinal tract to ionizing radiation J Immunol 153 1994 4230 4237
35. Neta R Oppenheim JJ Douches SD Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocytemacrophage colony-stimulating factor J Immunol 140 1988 108 111
36. Onozaki K Matsushima K Aggarwal BB Human interleukin 1 is a cytocidal factor for several tumor cell lines J Immunol 135 1985 3962 3968
37. Old LJ Tumor necrosis factor (TNF) Science 230 1985 630 632
38. Hallahan DE Beckett MA Kufe D The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines Proc Natl Acad Sci USA 19 1990 69 74
39. Carswell EA Old LJ Kassel RL An endotoxin-induced serum factor that causes necrosis of tumors Proc Natl Acad Sci USA 72 1975 3666 3670
40. Sugarman HJ Aggarwal BB Hass PE Recombinant human tumor necrosis factor: Effects on proliferation of normal and transformed cells in vitro Science 230 1985 943 945
41. Prehn JHM Bindokas VP Jordan J Protective effect of transforming growth factor-β1 on β-amyloid neurotoxicity in β-amyloid neurotoxicity in rat hippocampal neurons Mol Pharmacol 49 1996 319 328
42. Prehn JHM Bindokas VP Marcuccilli CJ Regulation of neuronal Bc12 protein expression and calcium homeostasis by transforming growth factor type β confers wide-ranging protection on rat hippocampal neurons Proc Natl Acad Sci USA 91 1994 12599 12603
43. McBride WH Economou JS Kuber N Modification of tumor microenvironment by cytokine gene transfer Acta Oncol 34 1995 447 451
44. Neta R Vogel SN Sipe JD Comparison of in vivo effects of human recombinant IL 1 and human recombinant IL 6 in mice Lymphokine Res 7 1988 403 412
45. Neta R Oppenheim JJ Schreiber RD Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor beta) in natural and lipopolysaccharide-enhanced radio-resistance J Exp Med 173 1991 1177 1182
46. [Review] Neta R Oppenheim JJ Radioprotection with cytokines—learning from nature to cope with radiation damage Cancer Cells 3 1991 391 396
47. [Review] Angioli R Sevin BU Perras JP Rationale of combining radiation and interferon for the treatment of cervical cancer Oncology 49 1992 445 449
48. Angioli R Sevin BU Perras JP In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell lines Cancer 71 1993 3717 3725
49. Seung LP Mauceri HJ Beckett MA Genetic radiotherapy overcomes resistance to cytotoxic agents Cancer Res 55 1995 5561 5565
50. Weichselbaum RR Hallahan DE Beckett MA Radiation targeting of gene therapy preferentially radiosensitizes tumor cells Cancer Res 54 1994 4266 4269
51. Weichselbaum RR Wayne JD Mauceri HJ Ionizing radiation: A molecular switch for gene therapy Sobol RE Scanlon KJ The Internet Book of Gene Therapy 1995 Appleton & Lange Stamford CT 205 210
52. Hallahan DE Sukhatme VP Sherman ML Protein kinase-C mediates x-ray inducibility of nuclear signal transducers, egr-1 and c-jun Proc Natl Acad Sci USA 88 1991 2152 2160
53. Datta R Rubin E Sukhatme V Ionizing radiation activates transcription of the Egr-1 gene via CArG elements Proc Natl Acad Sci USA 89 1992 10149 10153
54. Hallahan DE Vokes E Rubin SJ Phase I trial of tumor necrosis factor combined with radiotherapy Cancer J 1 1995 204 209
55. Kahn JO Kaplan LD Volberding PA Intralesional recombinant tumor necrosis factor-alpha for AIDS-associated Kaposi's sarcoma: A randomized, double-blind trial J Acquir Immune Defic Syndr 2 1989 217 223
56. Lienard D Lejeune FJ Ewalenko P In transit metastases of malignant melanoma treated by high dose rTNF alpha in combination with interferon-gamma and melphalan in isolation perfusion World J Surg 16 1992 234 240
57. [see comments] Culver KW Ram Z Wallbridge S In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors Science 256 1992 1550 1552
58. Freeman SM Abboud CN Whartenby KA The “by-stander effect”: Tumor regression when a fraction of the tumor mass is genetically modified Cancer Res 53 1993 5274 5283
59. Ram Z Walbridge S Shawker T The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats J Neurosurg 81 1994 256 260
60. Vile RG Hart IR Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA Cancer Res 53 1993 3860 3864
61. Mullen CA Coale MM Lowe R Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-flourocytosine and induce protective immunity to wild type tumor Cancer Res 54 1994 1503 1506
62. Mullen CA Kilstrup M Blaese RM Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system Proc Natl Acad Sci USA 89 1992 33 37
63. Huber BE Austin EA Good SS In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase Cancer Res 53 1993 4619 4626
64. Khil MS Kim JH Mullen CA Radiosensitization by 5-fluorotosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene Clin Cancer Res 2 1996 53 57
65. Kim JH Kim SH Brown SL Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV-tk gene Cancer Res 54 1994 6053 6056
66. Kim JH Kim SH Kolozsvary A Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 91 gliosarcoma cells in vitro and 9L vivo by antiviral agents Int J Radiat Oncol Biol Phys 33 1995 861 868